These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1132 related items for PubMed ID: 26735577

  • 1. Notch and Wnt/β-catenin signaling pathway play important roles in activating liver cancer stem cells.
    Wang R, Sun Q, Wang P, Liu M, Xiong S, Luo J, Huang H, Du Q, Geller DA, Cheng B.
    Oncotarget; 2016 Feb 02; 7(5):5754-68. PubMed ID: 26735577
    [Abstract] [Full Text] [Related]

  • 2. miR-942 promotes cancer stem cell-like traits in esophageal squamous cell carcinoma through activation of Wnt/β-catenin signalling pathway.
    Ge C, Wu S, Wang W, Liu Z, Zhang J, Wang Z, Li R, Zhang Z, Li Z, Dong S, Wang Y, Xue Y, Yang J, Tan Q, Wang Z, Song X.
    Oncotarget; 2015 May 10; 6(13):10964-77. PubMed ID: 25844602
    [Abstract] [Full Text] [Related]

  • 3. ELK3 promotes the migration and invasion of liver cancer stem cells by targeting HIF-1α.
    Lee JH, Hur W, Hong SW, Kim JH, Kim SM, Lee EB, Yoon SK.
    Oncol Rep; 2017 Feb 10; 37(2):813-822. PubMed ID: 27959451
    [Abstract] [Full Text] [Related]

  • 4. iNOS promotes CD24+CD133+ liver cancer stem cell phenotype through a TACE/ADAM17-dependent Notch signaling pathway.
    Wang R, Li Y, Tsung A, Huang H, Du Q, Yang M, Deng M, Xiong S, Wang X, Zhang L, Geller DA, Cheng B, Billiar TR.
    Proc Natl Acad Sci U S A; 2018 Oct 23; 115(43):E10127-E10136. PubMed ID: 30297396
    [Abstract] [Full Text] [Related]

  • 5. 8-bromo-7-methoxychrysin inhibits properties of liver cancer stem cells via downregulation of β-catenin.
    Quan MF, Xiao LH, Liu ZH, Guo H, Ren KQ, Liu F, Cao JG, Deng XY.
    World J Gastroenterol; 2013 Oct 23; 19(43):7680-95. PubMed ID: 24431896
    [Abstract] [Full Text] [Related]

  • 6. Krüppel-like factor 8 promotes cancer stem cell-like traits in hepatocellular carcinoma through Wnt/β-catenin signaling.
    Shen YN, He HG, Shi Y, Cao J, Yuan JY, Wang ZC, Shi CF, Zhu N, Wei YP, Liu F, Huang JL, Yang GS, Lu JH.
    Mol Carcinog; 2017 Feb 23; 56(2):751-760. PubMed ID: 27478926
    [Abstract] [Full Text] [Related]

  • 7. Histone demethylase JMJD2D promotes the self-renewal of liver cancer stem-like cells by enhancing EpCAM and Sox9 expression.
    Deng Y, Li M, Zhuo M, Guo P, Chen Q, Mo P, Li W, Yu C.
    J Biol Chem; 2021 Feb 23; 296():100121. PubMed ID: 33434575
    [Abstract] [Full Text] [Related]

  • 8. Overexpression of microRNA-21 strengthens stem cell-like characteristics in a hepatocellular carcinoma cell line.
    Jiang J, Yang P, Guo Z, Yang R, Yang H, Yang F, Li L, Xiang B.
    World J Surg Oncol; 2016 Oct 28; 14(1):278. PubMed ID: 27793160
    [Abstract] [Full Text] [Related]

  • 9. Musashi2 contributes to the maintenance of CD44v6+ liver cancer stem cells via notch1 signaling pathway.
    Wang X, Wang R, Bai S, Xiong S, Li Y, Liu M, Zhao Z, Wang Y, Zhao Y, Chen W, Billiar TR, Cheng B.
    J Exp Clin Cancer Res; 2019 Dec 30; 38(1):505. PubMed ID: 31888685
    [Abstract] [Full Text] [Related]

  • 10. SOX1 functions as a tumor suppressor by antagonizing the WNT/β-catenin signaling pathway in hepatocellular carcinoma.
    Tsao CM, Yan MD, Shih YL, Yu PN, Kuo CC, Lin WC, Li HJ, Lin YW.
    Hepatology; 2012 Dec 30; 56(6):2277-87. PubMed ID: 22767186
    [Abstract] [Full Text] [Related]

  • 11. Ack1 overexpression promotes metastasis and indicates poor prognosis of hepatocellular carcinoma.
    Lei X, Li YF, Chen GD, Ou DP, Qiu XX, Zuo CH, Yang LY.
    Oncotarget; 2015 Dec 01; 6(38):40622-41. PubMed ID: 26536663
    [Abstract] [Full Text] [Related]

  • 12. The Notch pathway promotes the cancer stem cell characteristics of CD90+ cells in hepatocellular carcinoma.
    Luo J, Wang P, Wang R, Wang J, Liu M, Xiong S, Li Y, Cheng B.
    Oncotarget; 2016 Feb 23; 7(8):9525-37. PubMed ID: 26848615
    [Abstract] [Full Text] [Related]

  • 13. Tankyrase inhibitors attenuate WNT/β-catenin signaling and inhibit growth of hepatocellular carcinoma cells.
    Ma L, Wang X, Jia T, Wei W, Chua MS, So S.
    Oncotarget; 2015 Sep 22; 6(28):25390-401. PubMed ID: 26246473
    [Abstract] [Full Text] [Related]

  • 14. CD44 is functionally crucial for driving lung cancer stem cells metastasis through Wnt/β-catenin-FoxM1-Twist signaling.
    Su J, Wu S, Wu H, Li L, Guo T.
    Mol Carcinog; 2016 Dec 22; 55(12):1962-1973. PubMed ID: 26621583
    [Abstract] [Full Text] [Related]

  • 15. Downregulation of SLC5A8 inhibits hepatocellular carcinoma progression through regulation of Wnt/β-catenin signaling.
    Hu BS, Xiong SM, Li G, Li JP.
    Tumour Biol; 2016 Oct 22; 37(10):13445-13453. PubMed ID: 27465549
    [Abstract] [Full Text] [Related]

  • 16. Overexpression of Klotho suppresses liver cancer progression and induces cell apoptosis by negatively regulating wnt/β-catenin signaling pathway.
    Sun H, Gao Y, Lu K, Zhao G, Li X, Li Z, Chang H.
    World J Surg Oncol; 2015 Oct 24; 13():307. PubMed ID: 26499380
    [Abstract] [Full Text] [Related]

  • 17. Metallothionein 1H (MT1H) functions as a tumor suppressor in hepatocellular carcinoma through regulating Wnt/β-catenin signaling pathway.
    Zheng Y, Jiang L, Hu Y, Xiao C, Xu N, Zhou J, Zhou X.
    BMC Cancer; 2017 Feb 28; 17(1):161. PubMed ID: 28241806
    [Abstract] [Full Text] [Related]

  • 18. CWP232228 targets liver cancer stem cells through Wnt/β-catenin signaling: a novel therapeutic approach for liver cancer treatment.
    Kim JY, Lee HY, Park KK, Choi YK, Nam JS, Hong IS.
    Oncotarget; 2016 Apr 12; 7(15):20395-409. PubMed ID: 26967248
    [Abstract] [Full Text] [Related]

  • 19. Growth differentiation factor 15 induces growth and metastasis of human liver cancer stem-like cells via AKT/GSK-3β/β-catenin signaling.
    Xu Q, Xu HX, Li JP, Wang S, Fu Z, Jia J, Wang L, Zhu ZF, Lu R, Yao Z.
    Oncotarget; 2017 Mar 07; 8(10):16972-16987. PubMed ID: 28199981
    [Abstract] [Full Text] [Related]

  • 20. Decreased Expression of Fructose-1,6-bisphosphatase Associates with Glucose Metabolism and Tumor Progression in Hepatocellular Carcinoma.
    Hirata H, Sugimachi K, Komatsu H, Ueda M, Masuda T, Uchi R, Sakimura S, Nambara S, Saito T, Shinden Y, Iguchi T, Eguchi H, Ito S, Terashima K, Sakamoto K, Hirakawa M, Honda H, Mimori K.
    Cancer Res; 2016 Jun 01; 76(11):3265-76. PubMed ID: 27197151
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 57.